Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06578702
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
Evaluation of Intermittent Triple Therapies in Real Life
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Intermittent Triple Therapies in Real Life
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ETRIVIE
Brief Summary:
The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR There is little data in real life as shown in the meta-analysis of Parienti JJ et al
Currently this strategy is proposed by some teams in France but is not recommended internationally
The research hypothesis is that intermittent treatment is an effective and safe option in a therapeutic lightening strategy in people living with HIV People living with HIV adults followed in Strasbourg who have benefited from intermittent treatment The expected results will consist of an improvement in knowledge on the efficacy and tolerance of this therapeutic strategy
Currently this strategy is proposed by some teams in France but is not recommended internationally
The research hypothesis is that intermittent treatment is an effective and safe option in a therapeutic lightening strategy in people living with HIV People living with HIV adults followed in Strasbourg who have benefited from intermittent treatment The expected results will consist of an improvement in knowledge on the efficacy and tolerance of this therapeutic strategy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None